GF
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Utility of the Amygdalar Atrophy Scale to Identify Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Memory Clinic | Neurology | 2026 | 1 | 0 | |||
| Gut microbiome signatures in iNPH : Insights from a shotgun metagenomics study | PloS one | 2025 | 28 | 142 | |||
| Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model | Frontiers in aging neuroscience | 2025 | 133 | 189 | |||
| Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease | Neurology | 2025 | 14 | 163 | |||
| Dopaminergic deficits along the spectrum of Alzheimer’s disease | Molecular psychiatry | 2025 | 16 | 0 | |||
| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging | 2025 | 16 | 103 | |||
| Resilience in Alzheimer's disease: Impact of operationalization and methodological choices | Alzheimer's & dementia | 2025 | 127 | 237 | |||
| Fecal Microbiota Transplantation ( FMT ) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model | Genes, brain and behavior | 2025 | 97 | 71 | |||
| Biomarqueurs sanguins : le Sherlock Holmes pour démasquer la maladie d’Alzheimer | Revue médicale suisse | 2025 | 113 | 3 | |||
| Anti-amyloid monoclonal antibodies for the treatment of Alzheimer disease: Intersocietal recommendations for their appropriate use in Switzerland | Neurodegenerative diseases | 2025 | 50 | 32 | |||
| Exploring the dimensionality of a neuropsychological test battery in a memory clinic setting using psychometric network analysis | 18th Conference of the Swiss Psychological Society | 2025 | 21 | 1 | |||
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | 2025 | 18 | 343 | |||
| The Bern Declaration on Brain Health : a decalogue to launch an international alliance | Lancet neurology | 2025 | 27 | 49 | |||
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | 2024 | 9 | 118 | |||
| Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia : an updated systematic review | European journal of nuclear medicine and molecular imaging | 2024 | 95 | 0 | |||
| Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of neurology | 2024 | 116 | 52 | |||
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2024 | 89 | 74 | |||
| A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images | European journal of nuclear medicine and molecular imaging | 2024 | 129 | 87 | |||
| Fingerprints of brain disease : connectome identifiability in Alzheimer's disease | Communications biology | 2024 | 204 | 83 | |||
| European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders | Lancet neurology | 2024 | 124 | 0 | |||
| A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings | Nature communications | 2024 | 94 | 32 | |||
| Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients | Alzheimer's research & therapy | 2024 | 155 | 161 | |||
| Insights into single-timepoint ASL hemodynamics: what visual assessment and spatial coefficient of variation can tell | La Radiologia medica | 2024 | 77 | 52 | |||
| Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer’s disease | Neurobiology of aging | 2024 | 124 | 168 | |||
| The emerging field of non-invasive brain stimulation in Alzheimer's disease | Brain | 2024 | 50 | 249 | |||
| Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats | Journal of Alzheimer's disease | 2024 | 92 | 57 | |||
| Alzheimer-Krankheit – Systembereitschaft im Kontext neuer Entwicklungen | Praxis | 2024 | 57 | 191 | |||
| Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers : The RECage Study | Journal of Alzheimer's disease | 2024 | 71 | 0 | |||
| Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease | Neurology | 2024 | 103 | 118 | |||
| Cognitive, psychological, and physiological effects of a web-based mindfulness intervention in older adults during the COVID-19 pandemic : an open study | BMC geriatrics | 2024 | 91 | 387 | |||
| Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up | Neurobiology of aging | 2024 | 73 | 69 | |||
| Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease | Neurobiology of aging | 2024 | 78 | 42 | |||
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | 2024 | 130 | 158 | |||
| In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant | Neurology | 2024 | 8 | 53 | |||
| Impact of simulated reduced injected dose on the assessment of amyloid PET scans | European journal of nuclear medicine and molecular imaging | 2024 | 141 | 55 | |||
| Microstructural alterations in the locus coeruleus-entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia | Alzheimer's & dementia. Diagnosis, assessment & disease monitoring | 2024 | 65 | 62 | |||
| Maladie d’Alzheimer : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 125 | 54 | |||
| Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer's disease | European journal of nuclear medicine and molecular imaging | 2023 | 84 | 288 | |||
| Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan | EJNMMI physics | 2023 | 67 | 22 | |||
| Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic | Journal of neurology, neurosurgery and psychiatry | 2023 | 266 | 204 | |||
| Resting state EEG rhythms in different stages of chronic kidney disease with mild cognitive impairment | Neurobiology of aging | 2023 | 85 | 178 | |||
| The Swiss Brain Health Plan 2023–2033 | Clinical and translational neuroscience | 2023 | 361 | 437 | |||
| Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning | Genome medicine | 2023 | 111 | 45 | |||
| Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits | Alzheimer's & dementia | 2023 | 142 | 125 | |||
| What a Single Electroencephalographic (EEG) Channel Can Tell us About Alzheimer's Disease Patients With Mild Cognitive Impairment | Clinical EEG and neuroscience | 2023 | 69 | 0 | |||
| A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers | Alzheimer's research & therapy | 2023 | 77 | 107 | |||
| Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease : Case Report and Review of the Literature | Journal of Alzheimer's disease | 2023 | 94 | 0 | |||
| Musical and psychomotor interventions for cognitive, sensorimotor, and cerebral decline in patients with Mild Cognitive Impairment (COPE): a study protocol for a multicentric randomized controlled study | BMC geriatrics | 2023 | 275 | 425 | |||
| Eigenvector centrality dynamics are related to Alzheimer's disease pathological changes in non-demented individuals | Brain communications | 2023 | 75 | 37 | |||
| Recycling brain scans with AI | Nature reviews. Neurology | 2023 | 61 | 0 | |||
| Respectful Caring for the Agitated Elderly (ReCAGE) : A Multicentre, Prospective, Observational Study to Evaluate the Effectiveness of Special Care Units for People with Dementia | Journal of Alzheimer's disease | 2023 | 110 | 125 | |||
| Recruitment of pre-dementia participants : main enrollment barriers in a longitudinal amyloid-PET study | Alzheimer's research & therapy | 2023 | 80 | 24 | |||
| Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study | Alzheimer's & dementia | 2023 | 147 | 160 | |||
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2023 | 99 | 105 | |||
| A Confirmatory and an Exploratory Factor Analysis of the Cohen-Mansfield Agitation Inventory (CMAI) in a European Case Series of Patients with Dementia : Results from the RECage Study | Brain sciences | 2023 | 92 | 196 | |||
| Analysis of psychological symptoms following disclosure of amyloid-positron emission tomography imaging results to adults with subjective cognitive decline | JAMA network open | 2023 | 94 | 113 | |||
| Patterns of amyloid accumulation in amyloid-negative cases | Neurobiology of aging | 2023 | 78 | 31 | |||
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | 2023 | 138 | 134 | |||
| Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients : The AMYPAD-DPMS Randomized Clinical Trial | JAMA neurology | 2023 | 73 | 74 | |||
| European consensus for the diagnosis of MCI and mild dementia: Preparatory phase | Alzheimer's & dementia | 2023 | 133 | 86 | |||
| Dementia prevention in memory clinics : recommendations from the european task force for brain health services | The Lancet regional health. Europe | 2023 | 119 | 211 | |||
| Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to Alzheimer's disease | Cerebral cortex | 2023 | 82 | 220 | |||
| STRIVEing to describe small vessel disease | Lancet neurology | 2023 | 53 | 0 | |||
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | 2023 | 179 | 273 | |||
| Outcome measures for Alzheimer's disease : A global inter-societal Delphi consensus | Alzheimer's & dementia | 2023 | 89 | 73 | |||
| Exploring the structure of a neuropsychological assessment with cognitively healthy adults | 17 th Conference of the Swiss Psychological Society | 2022 | 187 | 8 | |||
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience | 2022 | 167 | 1 | |||
| Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases | Neurobiology of aging | 2022 | 95 | 0 | |||
| From patients to disease: the difficult case of Alzheimer's | Lancet neurology | 2022 | 367 | 1 | |||
| Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol | Alzheimer disease and associated disorders | 2022 | 123 | 224 | |||
| Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia | Aging brain | 2022 | 64 | 26 | |||
| Radiological assessment of dementia: the Italian inter-society consensus for a practical and clinically oriented guide to image acquisition, evaluation, and reporting | La Radiologia medica | 2022 | 103 | 22 | |||
| Resting State Alpha Electroencephalographic Rhythms Are Affected by Sex in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment: A Retrospective and Exploratory Study | Cerebral cortex | 2022 | 94 | 0 | |||
| Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial | Nutrition journal | 2022 | 96 | 240 | |||
| An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers | Journal of Alzheimer's disease | 2022 | 109 | 0 | |||
| Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats | Journal of neuroinflammation | 2022 | 192 | 71 | |||
| Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study | Journal of neurology, neurosurgery and psychiatry | 2022 | 227 | 130 | |||
| Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice | Journal of Alzheimer's disease | 2022 | 359 | 1 | |||
| Deficient Novelty Detection and Encoding in Early Alzheimer's Disease: An ERP Study | Brain topography | 2022 | 134 | 156 | |||
| Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum | JAMA neurology | 2022 | 127 | 0 | |||
| Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model | BMC medical informatics and decision making | 2022 | 112 | 29 | |||
| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia | 2022 | 357 | 431 | |||
| Data-driven staging of genetic frontotemporal dementia using multi-modal MRI | Human brain mapping | 2022 | 111 | 147 | |||
| Early termination of pivotal trials in Alzheimer's disease — Preserving optimal value for participants and science | Alzheimer's & dementia | 2022 | 87 | 76 | |||
| Alzheimer's Disease with Epileptiform EEG Activity : Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment | Journal of Alzheimer's disease | 2022 | 70 | 0 | |||
| Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario | Biomedicines | 2022 | 65 | 215 | |||
| The amyloid imaging for the prevention of Alzheimer's disease consortium : A European collaboration with global impact | Frontiers in neurology | 2022 | 74 | 20 | |||
| Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset | Frontiers in aging neuroscience | 2022 | 119 | 66 | |||
| The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow | NeuroImage. Clinical | 2022 | 116 | 67 | |||
| Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study | Frontiers in psychiatry | 2022 | 84 | 114 | |||
| Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios | Alzheimer's & dementia. Diagnosis, assessment & disease monitoring | 2022 | 90 | 208 | |||
| A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET | European journal of nuclear medicine and molecular imaging | 2022 | 422 | 94 | |||
| What a single electroencephalographic (EEG) channel can tell us about patients with dementia due to Alzheimer's disease | International journal of psychophysiology | 2022 | 88 | 0 | |||
| Simulad: a dynamical model for personalized simulation and disease staging in alzheimer's disease | Neurobiology of aging | 2022 | 136 | 62 | |||
| The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging | Journal of Alzheimer's disease | 2022 | 214 | 145 | |||
| Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation | Molecular psychiatry | 2022 | 109 | 21 | |||
| Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation | Neurobiology of aging | 2022 | 129 | 260 | |||
| The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19 | Neurodegenerative diseases | 2022 | 126 | 276 | |||
| Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment | Neurology | 2022 | 161 | 206 | |||
| Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks | Frontiers in aging neuroscience | 2022 | 69 | 71 | |||
| Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study | Annals of neurology | 2022 | 132 | 106 | |||
| The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey | Journal of Alzheimer's disease | 2022 | 96 | 241 | |||
| Prendre soin du cerveau | Bulletin des médecins suisses | 2022 | 297 | 152 | |||
| MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia | Journal of neurology, neurosurgery and psychiatry | 2021 | 88 | 0 | |||
| Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study | Magnetic resonance imaging | 2021 | 109 | 0 | |||
| Le Registre suisse pour la santé du cerveau - Une infrastructure nationale pour la recherche sur la maladie d’Alzheimer | Revue médicale suisse | 2021 | 104 | 70 | |||
| Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment | Journal of Alzheimer's disease | 2021 | 80 | 0 | |||
| Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes | Alzheimer's & dementia | 2021 | 95 | 60 | |||
| Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6 | Alzheimer's research & therapy | 2021 | 186 | 341 | |||
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 344 | 227 | |||
| Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort | Biomedicines | 2021 | 110 | 45 | |||
| Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design | Alzheimer's Research and Therapy | 2021 | 447 | 405 | |||
| Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 | Alzheimer's research & therapy | 2021 | 225 | 282 | |||
| EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel | Neurobiology of aging | 2021 | 139 | 698 | |||
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging | 2021 | 223 | 259 | |||
| Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial | JAMA network open | 2021 | 131 | 48 | |||
| White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers | Journal of Alzheimer's disease | 2021 | 103 | 120 | |||
| Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia | Alzheimer's & dementia | 2021 | 98 | 87 | |||
| Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European‐DLB consortium project | Alzheimer's & Dementia | 2021 | 273 | 2 | |||
| Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group | Lancet neurology | 2021 | 197 | 3,669 | |||
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services — part 2 of 6 | Alzheimer's research & therapy | 2021 | 162 | 271 | |||
| Protocols for cognitive enhancement. a user manual for brain health services — part 5 of 6 | Alzheimer's research & therapy | 2021 | 161 | 197 | |||
| Stacked autoencoders as new models for an accurate Alzheimer's disease classification support using resting-state EEG and MRI measurements | Clinical neurophysiology | 2021 | 119 | 0 | |||
| Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project | Journal of Alzheimer's disease | 2021 | 118 | 167 | |||
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | 2021 | 244 | 306 | |||
| Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer's Disease and Neurodegeneration: Old Drugs, New Concerns | Frontiers in oncology | 2021 | 115 | 99 | |||
| Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome | Journal of Alzheimer's disease | 2021 | 216 | 0 | |||
| Inter-Cohort Validation of SuStaIn Model for Alzheimer's Disease | Frontiers in big data | 2021 | 109 | 340 | |||
| Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives | European journal of nuclear medicine and molecular imaging | 2021 | 226 | 124 | |||
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | 2021 | 129 | 147 | |||
| Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework | European journal of nuclear medicine and molecular imaging | 2021 | 266 | 274 | |||
| Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies | Frontiers in aging neuroscience | 2021 | 88 | 120 | |||
| TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels | Alzheimer's & dementia | 2021 | 123 | 158 | |||
| Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data | Brain communications | 2021 | 69 | 93 | |||
| Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model | Neurobiology of Aging | 2021 | 407 | 303 | |||
| Dementia risk communication. A user manual for Brain Health Services — part 3 of 6 | Alzheimer's research & therapy | 2021 | 137 | 210 | |||
| Management of Alzheimer's disease takes a leap forward | Lancet neurology | 2021 | 79 | 0 | |||
| Disease-related cortical thinning in presymptomatic granulin mutation carriers | NeuroImage. Clinical | 2021 | 108 | 67 | |||
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 357 | 273 | |||
| In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases | Alzheimer's research & therapy | 2021 | 102 | 42 | |||
| Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment | Cerebral cortex | 2021 | 99 | 0 | |||
| Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia | JAMA network open | 2021 | 122 | 72 | |||
| Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer's disease in a cross-sectional multi-cohort study | Scientific reports | 2021 | 174 | 87 | |||
| Convergent and Discriminant Validity of Default Mode Network and Limbic Network Perfusion in Amnestic Mild Cognitive Impairment Patients | Journal of Alzheimer's disease | 2021 | 89 | 0 | |||
| Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel | Alzheimer's & dementia | 2021 | 133 | 1,025 | |||
| Norms for Automatic Estimation of Hippocampal Atrophy and a Step Forward for Applicability to the Italian Population | Frontiers in neuroscience | 2021 | 106 | 35 | |||
| Replication study of plasma proteins relating to Alzheimer's pathology | Alzheimer's & dementia | 2021 | 217 | 144 | |||
| Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | 2021 | 199 | 105 | |||
| Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET) | Alzheimer's & dementia. Translational research & clinical interventions | 2021 | 111 | 160 | |||
| Automatic multispectral MRI segmentation of human hippocampal subfields: an evaluation of multicentric test-retest reproducibility | Brain structure & function | 2021 | 95 | 26 | |||
| Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics | European journal of nuclear medicine and molecular imaging | 2021 | 241 | 0 | |||
| L-sérine : l’antisèche de la mémoire | Revue médicale suisse | 2021 | 255 | 231 | |||
| Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort | Journal of Alzheimer's Disease | 2020 | 364 | 341 | |||
| Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease? | Journal of Alzheimer's Disease | 2020 | 527 | 2 | |||
| Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias | Lancet neurology | 2020 | 277 | 0 | |||
| Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease | Journal of Alzheimer's Disease | 2020 | 468 | 8 | |||
| Multitracer model for staging cortical amyloid deposition using PET imaging | Neurology | 2020 | 14 | 90 | |||
| Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study | Aging Clinical and Experimental Research | 2020 | 457 | 1 | |||
| Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer's disease | Brain Imaging and Behavior | 2020 | 351 | 3 | |||
| Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies | Movement Disorders | 2020 | 388 | 169 | |||
| Cortical Superficial Siderosis: A Descriptive Analysis in a Memory Clinic Population | Journal of Alzheimer's Disease | 2020 | 478 | 0 | |||
| Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education | Neurobiology of Aging | 2020 | 446 | 0 | |||
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 414 | 6 | |||
| Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors | NeuroImage | 2020 | 349 | 434 | |||
| Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study | Alzheimer's & Dementia | 2020 | 502 | 174 | |||
| CSF cutoffs for MCI due to AD depend on APOEε4 carrier status | Neurobiology of Aging | 2020 | 294 | 2 | |||
| A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment | Current Alzheimer research | 2020 | 108 | 265 | |||
| Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study | Neurobiology of Aging | 2020 | 447 | 3 | |||
| Learning from the Past: a Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease | Current Alzheimer Research | 2020 | 359 | 7 | |||
| Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies | Alzheimer's & Dementia | 2020 | 265 | 2 | |||
| Comparison of Bioinformatics Pipelines and Operating Systems for the Analyses of 16S rRNA Gene Amplicon Sequences in Human Fecal Samples | Frontiers in Microbiology | 2020 | 446 | 244 | |||
| Metabolic patterns across core features in dementia with lewy bodies | Annals of Neurology | 2019 | 415 | 2 | |||
| Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases | Neurobiology of Aging | 2019 | 468 | 1 | |||
| Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease | NeuroImage: Clinical | 2019 | 327 | 276 | |||
| Re-aligning scientific and lay narratives of Alzheimer's disease | The Lancet Neurology | 2019 | 257 | 1 | |||
| Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia | Neurobiology of Aging | 2019 | 326 | 206 | |||
| Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study | The Lancet Neurology | 2019 | 396 | 1 | |||
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 425 | 6 | |||
| Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms | Neurobiology of Aging | 2019 | 458 | 0 | |||
| Applying the ATN scheme in a memory clinic population: The ABIDE project | Neurology | 2019 | 422 | 1 | |||
| Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) | NeuroImage: Clinical | 2019 | 354 | 186 | |||
| Brain imaging working group summaries for the european joint programme for neurodegenerative disease research | Alzheimer's & Dementia | 2019 | 481 | 209 | |||
| Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study | Brain | 2019 | 343 | 151 | |||
| A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort | Alzheimer's & dementia | 2019 | 476 | 236 | |||
| Whole-brain microstructural white matter alterations in borderline personality disorder patients | Personality and Mental Health | 2019 | 281 | 0 | |||
| Medial temporal lobe atrophy and posterior atrophy scales normative values | NeuroImage: Clinical | 2019 | 503 | 358 | |||
| Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease | Journal of Alzheimer's Disease | 2019 | 354 | 572 | |||
| IDEAS becoming reality on the roadmap for biomarker validation in Alzheimer's disease | The Lancet Neurology | 2019 | 306 | 0 | |||
| White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study | NeuroImage: Clinical | 2019 | 372 | 235 | |||
| Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay | Alzheimer's & Dementia | 2019 | 331 | 312 | |||
| miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease | Neurobiology of Aging | 2019 | 341 | 1 | |||
| Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions | Alzheimer's & dementia | 2019 | 302 | 171 | |||
| Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset | Journal of Neurology | 2019 | 347 | 391 | |||
| Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers | Journal of Alzheimer's Disease | 2019 | 423 | 5 | |||
| Is a large-scale screening for Alzheimer's disease possible? yes, in a few years | The Journal of Prevention of Alzheimer's Disease | 2019 | 309 | 7 | |||
| One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI) | Journal of Alzheimer's Disease | 2019 | 283 | 0 | |||
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study | The Lancet Neurology | 2019 | 369 | 0 | |||
| Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort | Alzheimer's & Dementia | 2019 | 308 | 266 | |||
| Next Generation Sequencing Analysis in Early Onset Dementia Patients | Journal of Alzheimer's Disease | 2019 | 286 | 349 | |||
| Head-to-head comparison among semi-quantification tools of brain FDG-PET to aid the diagnosis of prodromal Alzheimer's disease | Journal of Alzheimer's Disease | 2019 | 325 | 550 | |||
| Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia | Neurobiology of Aging | 2018 | 467 | 192 | |||
| Hybrid PET-MRI in Alzheimer's Disease Research | Methods in Molecular Biology | 2018 | 591 | 1 | |||
| Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort | Journal of Alzheimer's Disease | 2018 | 412 | 0 | |||
| Education-Adjusted Normality Thresholds for FDG-PET in the Diagnosis of Alzheimer Disease | Neurodegenerative Diseases | 2018 | 475 | 0 | |||
| The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research and Therapy | 2018 | 497 | 0 | |||
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease | Alzheimer's & Dementia | 2018 | 459 | 3 | |||
| Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort | NeuroImage | 2018 | 381 | 233 | |||
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 473 | 0 | |||
| One step towards dementia prevention | The Lancet Neurology | 2018 | 361 | 1 | |||
| MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study | Alzheimer's Research and Therapy | 2018 | 481 | 369 | |||
| Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study | Journal of Alzheimer's Disease | 2018 | 410 | 0 | |||
| Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial | PLOS Medicine | 2018 | 437 | 235 | |||
| Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 438 | 0 | |||
| Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation | Journal of Alzheimer's Disease | 2018 | 397 | 0 | |||
| Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET | Alzheimer's & Dementia | 2018 | 451 | 0 | |||
| Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study | Journal of Alzheimer's Disease | 2018 | 405 | 0 | |||
| Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study | Annals of Clinical and Translational Neurology | 2018 | 422 | 166 | |||
| Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study | Neurobiology of Aging | 2018 | 456 | 271 | |||
| Clinical utility of FDG-PET for the clinical diagnosis in MCI | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 455 | 0 | |||
| Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 457 | 0 | |||
| Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales | Alzheimer's Research and Therapy | 2018 | 340 | 170 | |||
| Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases | Clinical Neurophysiology | 2018 | 389 | 0 | |||
| L'atrophie du lobe temporal mésial détectée par IRM en tant que biomarqueur de la maladie d'Alzheimer | Revue médicale suisse | 2018 | 1,003 | 1,431 | |||
| Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial | Journal of Alzheimer's Disease | 2018 | 568 | 0 | |||
| Non-Invasive Brain Stimulation in Dementia: A Complex Network Story | Neurodegenerative Diseases | 2018 | 403 | 1 | |||
| Brain FDG-PET: clinical use in dementing neurodegenerative conditions | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 371 | 0 | |||
| Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases | Journal of Alzheimer's Disease | 2018 | 424 | 0 | |||
| Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study | Neurobiology of Aging | 2018 | 361 | 1 | |||
| Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia | JAMA Psychiatry | 2018 | 532 | 408 | |||
| Immune and metabolic alterations in first episode psychosis (FEP) patients | Brain, Behavior and Immunity | 2018 | 334 | 0 | |||
| Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference | Nature Communications | 2018 | 455 | 318 | |||
| Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation | Psychiatry Research: Neuroimaging | 2018 | 487 | 1 | |||
| AMYPAD Diagnostic and Patient Management Study: Rationale and design | Alzheimer's & Dementia | 2018 | 477 | 332 | |||
| Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Networks | Journal of Alzheimer's disease | 2017 | 491 | 0 | |||
| The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues | Neurobiology of aging | 2017 | 522 | 7 | |||
| Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index | Journal of Alzheimer's disease | 2017 | 628 | 0 | |||
| The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology | Neurobiology of Aging | 2017 | 519 | 2 | |||
| Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) | Neurobiology of aging | 2017 | 581 | 2 | |||
| Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations | Alzheimer's Research & Therapy | 2017 | 428 | 191 | |||
| Effectiveness of Florbetapir PET Imaging in Changing Patient Management | Dementia and Geriatric Cognitive Disorders | 2017 | 522 | 198 | |||
| The frequency and influence of dementia risk factors in prodromal Alzheimer's disease | Neurobiology of aging | 2017 | 500 | 3 | |||
| Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study | Journal of Alzheimer's Disease | 2017 | 478 | 2 | |||
| Alzheimer's disease biomarker development: a call to funding bodies | Neurobiology of aging | 2017 | 492 | 10 | |||
| Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects | Human brain mapping | 2017 | 404 | 1 | |||
| Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia | Alzheimer's & dementia | 2017 | 548 | 361 | |||
| Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis | JAMA Neurology | 2017 | 690 | 2 | |||
| Probabilistic disease progression modeling to characterize diagnostic uncertainty: Application to staging and prediction in Alzheimer's disease | NeuroImage | 2017 | 421 | 0 | |||
| Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging | 2017 | 414 | 0 | |||
| FDG PET/MR imaging in major neurocognitive disorders | Current Alzheimer research | 2017 | 762 | 6 | |||
| Démences frontotemporales: mise à jour | Revue médicale suisse | 2017 | 955 | 742 | |||
| Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study | NeuroImage | 2017 | 448 | 0 | |||
| The European DTI Study on Dementia - A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment | NeuroImage | 2017 | 476 | 0 | |||
| Microbiota and neurodegenerative diseases | Current Opinion in Neurology | 2017 | 522 | 5 | |||
| Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap | Neurobiology of aging | 2017 | 505 | 1 | |||
| Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota | Scientific reports | 2017 | 594 | 305 | |||
| 'Reverse expansion': A new technique of breast reconstruction with autologous tissue | Journal of Plastic, Reconstructive & Aesthetic Surgery | 2017 | 504 | 520 | |||
| Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study | Brain | 2017 | 478 | 251 | |||
| The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study | Alzheimer's & Dementia | 2017 | 484 | 4 | |||
| Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study | Neurobiology of aging | 2017 | 625 | 3 | |||
| Guide à la lecture et interprétation de l'imagerie PET des plaques amyloïdes | Médecine nucléaire | 2017 | 521 | 6 | |||
| Association of postoperative delirium with markers of neurodegeneration and brain amyloidosis: a pilot study | Neurobiology of Aging | 2017 | 526 | 769 | |||
| Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment | Alzheimer's & dementia | 2017 | 535 | 160 | |||
| Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features | Journal of Alzheimer's Disease | 2017 | 476 | 0 | |||
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers | The Lancet Neurology | 2017 | 692 | 7 | |||
| TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis | Human mutation | 2017 | 409 | 265 | |||
| Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study | Journal of Alzheimer's Disease | 2017 | 511 | 1 | |||
| Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes | Journal of Alzheimer's disease | 2017 | 528 | 1 | |||
| Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio | Neurobiology of Aging | 2017 | 587 | 1 | |||
| White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort | NeuroImage: Clinical | 2017 | 497 | 200 | |||
| Determinants of Quality of Life in Ageing Populations: Results from a Cross-Sectional Study in Finland, Poland and Spain | PloS one | 2016 | 469 | 295 | |||
| Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease | NeuroImage | 2016 | 706 | 4 | |||
| Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient? | Lancet neurology | 2016 | 463 | 0 | |||
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Neurobiology of aging | 2016 | 764 | 3 | |||
| Suspected non-Alzheimer disease pathophysiology — concept and controversy | Nature reviews. Neurology | 2016 | 494 | 2 | |||
| Diagnostic et prise en charge des démences : des concepts en pleine évolution | Revue médicale suisse | 2016 | 307 | 2 | |||
| Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic | Neurodegenerative Diseases | 2016 | 425 | 1 | |||
| The habenula: an under-recognised area of importance in frontotemporal dementia? | Journal of neurology, neurosurgery and psychiatry | 2016 | 487 | 0 | |||
| Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms | Frontiers in neuroscience | 2016 | 546 | 294 | |||
| Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease | Psychiatry research. Neuroimaging | 2016 | 480 | 0 | |||
| Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria | Alzheimer's & dementia | 2016 | 877 | 5 | |||
| MRI for Pre-Dementia Trials | The Journal of Prevention of Alzheimer's Disease | 2016 | 330 | 0 | |||
| Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study | JAMA neurology | 2016 | 485 | 2 | |||
| Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis | Journal of Alzheimer's disease | 2016 | 499 | 1 | |||
| Imagerie cérébrale de la maladie d'Alzheimer : état de l'art et perspectives pour le clinicien | Revue médicale suisse | 2016 | 662 | 11 | |||
| Brain networks stimulation in dementia: insights from functional imaging | Current opinion in neurology | 2016 | 372 | 0 | |||
| Re: Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer's Disease (AD) | Radiotherapy and oncology | 2016 | 551 | 1 | |||
| Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks | Frontiers in Neuroscience | 2016 | 460 | 328 | |||
| Voxel-based morphometry study on monozygotic twins discordant for Alzheimer's disease | Acta Neurologica Scandinavica | 2016 | 409 | 0 | |||
| Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques | Human brain mapping | 2016 | 444 | 1 | |||
| Defeating Alzheimer's disease and other dementias: a priority for European science and society | Lancet neurology | 2016 | 694 | 5 | |||
| Brain atrophy in Alzheimer's Disease and aging | Ageing research reviews | 2016 | 742 | 7 | |||
| A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers | Neurology | 2016 | 450 | 0 | |||
| Alzheimer's disease | Lancet | 2016 | 603 | 9 | |||
| Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial | Lancet | 2016 | 535 | 0 | |||
| Automated hippocampal segmentation in 3D MRI using random undersampling with boosting algorithm | Pattern Analysis and Application | 2016 | 409 | 213 | |||
| Efficacy of lifestyle interventions on clinical and neuroimaging outcomes in elderly | Ageing research reviews | 2016 | 559 | 2 | |||
| Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study' | Journal of internal medicine | 2016 | 547 | 2 | |||
| Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study | Neurobiology of aging | 2016 | 444 | 0 | |||
| Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol | Journal of Alzheimer's disease | 2016 | 572 | 0 | |||
| Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease | Neurobiology of Aging | 2015 | 362 | 0 | |||
| Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly | Human brain mapping | 2015 | 544 | 4 | |||
| Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance | Alzheimer's & dementia | 2015 | 614 | 3 | |||
| Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics | Alzheimer's & dementia | 2015 | 545 | 0 | |||
| Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study | NeuroImage. Clinical | 2015 | 559 | 484 | |||
| Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol | Alzheimer's & dementia | 2015 | 650 | 2 | |||
| Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study | NeuroImage | 2015 | 501 | 2 | |||
| The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity | Alzheimer's & dementia | 2015 | 633 | 2 | |||
| Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index | Current Alzheimer Research | 2015 | 468 | 1 | |||
| Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele | Alzheimer's & dementia | 2015 | 590 | 2 | |||
| Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage | Brain | 2015 | 610 | 7 | |||
| Neurology : the next 10 years | Nature reviews. Neurology | 2015 | 348 | 1 | |||
| Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia | The American journal of geriatric psychiatry | 2015 | 511 | 0 | |||
| Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis | Lancet neurology | 2015 | 554 | 2 | |||
| Biomarkers for Alzheimer's disease: a controversial topic | Lancet neurology | 2015 | 430 | 3 | |||
| Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study | PloS one | 2015 | 575 | 379 | |||
| Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy | Neurological Sciences | 2015 | 397 | 0 | |||
| Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol | Alzheimer's & dementia | 2015 | 567 | 3 | |||
| Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images | Neurobiology of aging | 2015 | 626 | 2 | |||
| The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey | Alzheimer's & dementia | 2015 | 596 | 3 | |||
| Clinical trial design of serious gaming in mild cognitive impairment | Frontiers in aging neuroscience | 2015 | 545 | 662 | |||
| Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project | Alzheimer's & dementia | 2015 | 638 | 1 | |||
| The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update | Alzheimer's & dementia | 2015 | 503 | 1 | |||
| Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects | Brain | 2015 | 555 | 2 | |||
| Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study | Neurobiology of aging | 2015 | 549 | 2 | |||
| HarP: the EADC-ADNI Harmonized Protocol for manual hippocampal segmentation. A standard of reference from a global working group | Alzheimer's & dementia | 2015 | 391 | 0 | |||
| Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project | Journal of Alzheimer's disease | 2015 | 656 | 1 | |||
| Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia | Journal of neurology | 2015 | 539 | 0 | |||
| Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression | Neurology | 2015 | 468 | 2 | |||
| Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project | Alzheimer's & dementia | 2015 | 635 | 4 | |||
| Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge | NeuroImage | 2015 | 552 | 0 | |||
| Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation | Alzheimer's & dementia | 2015 | 487 | 0 | |||
| Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study | Neurobiology of aging | 2015 | 569 | 2 | |||
| Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker | Journal of Alzheimer's disease | 2015 | 519 | 0 | |||
| Abnormalities in cortical gray matter density in borderline personality disorder | European psychiatry | 2015 | 575 | 3 | |||
| Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force | JPAD | 2015 | 381 | 0 | |||
| Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis | Neurobiology of aging | 2015 | 608 | 4 | |||
| Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection | Lancet neurology | 2015 | 506 | 0 | |||
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | JAMA | 2015 | 613 | 2 | |||
| Multiple RF classifier for the hippocampus segmentation: Method and validation on EADC-ADNI Harmonized Hippocampal Protocol | Physica Medica | 2015 | 422 | 193 | |||
| Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology? | Alzheimer's research & therapy | 2014 | 546 | 241 | |||
| Abstracts of the IX Congresso Sindem: Italian Association for the study of Dementia linked to the Italian Neurological Society (SIN), March 13-15, 2014, Florence, Italy | Journal of Alzheimer's Disease | 2014 | 399 | 1 | |||
| The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging | Journal of Alzheimer's disease | 2014 | 695 | 4 | |||
| A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis | BioMed research international | 2014 | 635 | 485 | |||
| Medial temporal atrophy in early and late-onset Alzheimer's disease | Neurobiology of aging | 2014 | 525 | 2 | |||
| Automated voxel-by-voxel tissue classification for hippocampal segmentation: methods and validation | Physica Medica | 2014 | 409 | 0 | |||
| Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects | NeuroImage | 2014 | 618 | 3 | |||
| The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations | JPAD | 2014 | 468 | 0 | |||
| Impact of alcohol consumption in healthy adults: a magnetic resonance imaging investigation | Psychiatry Research | 2014 | 395 | 0 | |||
| Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis | Journal of Alzheimer's disease | 2014 | 588 | 0 | |||
| Pattern of structural and functional brain abnormalities in asymptomatic granulin mutation carriers | Alzheimer's & dementia | 2014 | 558 | 1 | |||
| A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia | Neuroinformatics | 2014 | 517 | 0 | |||
| Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion | Frontiers in aging neuroscience | 2014 | 588 | 261 | |||
| Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy | Nature reviews. Neurology | 2014 | 635 | 2 | |||
| Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol | Journal of Neuroimaging | 2014 | 415 | 0 | |||
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Lancet neurology | 2014 | 767 | 3 | |||
| Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease | Alzheimer's & dementia | 2014 | 528 | 1 | |||
| Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration | Acta neuropathologica | 2014 | 497 | 1 | |||
| Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI | Alzheimer disease and associated disorders | 2014 | 586 | 1 | |||
| Pre-interventional haemostatic assessment: Guidelines from the French Society of Anaesthesia and Intensive Care | European journal of anaesthesiology | 2013 | 1,034 | 2 | |||
| Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle | International Journal of Law and Psychiatry | 2013 | 360 | 0 | |||
| Structural brain features of borderline personality and bipolar disorders | Psychiatry Research | 2013 | 443 | 0 | |||
| Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease | Neurology | 2013 | 272 | 0 | |||
| Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study | Neurobiology of Aging | 2013 | 414 | 0 | |||
| Progression of Alzheimer disease in Europe: data from the European ICTUS study | Current Alzheimer research | 2012 | 600 | 5 | |||
| Norms for imaging markers of brain reserve | Journal of Alzheimer's Disease | 2012 | 432 | 0 | |||
| Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders | Psychiatry research. Neuroimaging | 2012 | 662 | 0 | |||
| Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia | Psychiatry research | 2011 | 643 | 0 | |||
| Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol | Journal of Alzheimer's Disease | 2011 | 415 | 0 | |||
| Cortex and amygdala morphology in psychopathy | Psychiatry Research | 2011 | 561 | 1 | |||
| Alzheimer's CSF markers in older schizophrenia patients | International journal of geriatric psychiatry | 2011 | 621 | 0 | |||
| Local amygdala structural differences with 3T MRI in patients with Alzheimer disease | Neurology | 2011 | 368 | 0 | |||
| The CST3 B haplotype is associated with frontotemporal lobar degeneration | European Journal of Neurology | 2010 | 277 | 0 | |||
| Abnormal hippocampal shape in offenders with psychopathy | Human Brain Mapping | 2010 | 361 | 0 | |||
| Clinical and medial temporal features in a family with mood disorders | Neuroscience Letters | 2010 | 400 | 0 | |||
| The primary care physician and Alzheimer's disease: an international position paper | The Journal of nutrition, health & aging | 2010 | 617 | 0 | |||
| H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers | European Journal of Human Genetics | 2009 | 395 | 0 | |||
| HOXA1 A218G polymorphism is associated with smaller cerebellar volume in healthy humans | Journal of Neuroimaging | 2009 | 392 | 0 | |||
| White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment | Human Brain Mapping | 2009 | 374 | 0 | |||
| Alexithymia in healthy women: a brain morphology study | Journal of Affective Disorders | 2009 | 380 | 1 | |||
| In vivo neuropathology of cortical changes in elderly persons with schizophrenia | Biological psychiatry | 2009 | 658 | 0 | |||
| The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions | Aging Clinical and Experimental Research | 2009 | 444 | 0 | |||
| Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter | Neuroscience Letters | 2008 | 382 | 0 | |||
| Hippocampal shape differences in dementia with Lewy bodies | NeuroImage | 2008 | 323 | 0 | |||
| The topography of grey matter involvement in early and late onset Alzheimer's disease | Brain | 2007 | 257 | 0 | |||
| Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study | Menopause | 2006 | 397 | 1 | |||
| The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study | Dementia and Geriatric Cognitive Disorders | 2006 | 449 | 0 | |||
| Topographic correspondence between white matter hyperintensities and brain atrophy | Journal of Neurology | 2006 | 396 | 0 | |||
| Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study | European Journal of Human Genetics | 2006 | 386 | 0 | |||
| Cognitive rehabilitation for severe dementia: critical observations for better use of existing knowledge | Mechanisms of Ageing and Development | 2006 | 358 | 0 | |||
| Effects of estrogens on cognition and brain morphology: involvement of the cerebellum | Maturitas | 2006 | 406 | 0 | |||
| Frontotemporal dementia as a neural system disease | Neurobiology of Aging | 2005 | 368 | 0 | |||
| APOE and modulation of Alzheimer's and frontotemporal dementia | Neuroscience Letters | 2004 | 325 | 0 | |||
| The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia | Neurobiology of Aging | 2003 | 375 | 0 | |||
| Clinical characteristics of frontotemporal patients with symmetric brain atrophy | European Archives of Psychiatry and Clinical Neuroscience | 2002 | 380 | 0 | |||
| Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease | Neuroscience Letters | 2002 | 393 | 1 | |||
| Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease | Annals of Neurology | 1995 | 246 | 0 |
